In addition to having had the good taste to invent India Quantum Ale, this PhD in micromagnet engineering founded Nord Quantique in ... Quobly are all the fruit of France's elite universities.

we can deploy our projects in France and Germany at the same time, enabling us to grow on a European scale.” Beginning life as The Challenge Project, a research endeavour in collaboration with Region ...

Purvi Tailor, Ferring Pharmaceuticals' VP of HR, says focusing holistically on worker well-being is crucial for retaining top ...

When reached for comment, Sanofi pointed Fierce Pharma to an announcement from Oct ... markets transaction to create a listed entity in France. Sanofi’s consumer health business pulled in ...

OnePlus Nord 4 is a solid mid-range phone featuring a powerful Qualcomm Snapdragon chipset, a 50MP dual rear camera setup, and a massive 5,000mAh battery — the highest ever on a OnePlus phone ...

In the life sciences industry in particular, leading pharma companies are already deploying this technology across their own operations to spur productivity and efficiency for mundane, time ...

The bloc is prepared for a zero-transit scenario its energy chief has claimed Any new deal to keep Russian gas flowing to the ...

Commercial dose companies form a critical component of the pharmaceutical manufacturing industry’s value chain. Commercial dose form manufacturing follows API manufacturing to produce the final ...

France's government is to deliver its 2025 budget on Thursday with plans for 60 billion euros ($65.68 billion) worth of tax hikes and spending cuts to tackle a spiralling fiscal deficit.

France is expected to finalise a new government by Sunday, with President Emmanuel Macron and Prime Minister Michel Barnier negotiating a cabinet reshuffle that marks a shift to the right.

Divi’s Laboratories Limited specialises in producing active pharmaceutical ingredients and intermediates. The company is engaged in the manufacturing and custom synthesis of generic APIs and ...

These drugs are produced by several pharmaceutical companies. Some firms have denied responsibility, calling the products spurious. In August, the CDSCO banned over 156 fixed-dose combinations.